Pathogenesis and characterization of hyperglucagonemia in the uremic rat.
Open Access
- 1 November 1976
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 58 (5), 1266-1272
- https://doi.org/10.1172/jci108581
Abstract
The pathogenesis of hyperglucagonemia and of the alterations in the pattern of circulating immunoreactive glucagon (IRG) associated with renal insufficiency was studied in rats in which a comparable degree of uremia was induced by three different methods, i.e., bilateral nephrectomy, bilateral ureteral ligation, and urine autoinfusion. Nephrectomized and ureteral-ligated rats were markedly hyperglucagonemic (575 +/- 95 pg/ml and 492 +/- 54 pg/ml, respectively), while IRG levels of urine autoinfused animals (208 +/- 35 pg/ml) were similar to those of control rats (180 +/- 26 pg/ml), indicating that uremia per se does not account for the hyperglucagonemia observed in renal failure. Similarly, plasma IRG composition in this group of animals was indistinguishable from that of controls, in which 88.2 +/- 5.9% of total IRG consisted of the 3,500-mol wt fraction. The same component was almost entirely responsible (82.6 +/- 4.1%) for the hyperglucagonemia observed in ligated rats, while it accounted for only 57.6 +/- 5.0% of the circulating IRG in nephrectomized animals. In the latter group, 36.8 +/- 6.6% of total IRG had a mol wt of approximately 9,000, consistent with a glucagon precursor. This peak was present in samples obtained as early as 2 h after renal ablation and its concentration continued to increase with time reaching maximal levels at 24 h. These results confirm that the kidney is a major site of glucagon metabolism and provide evidence that the renal handling of the various circulating IRG components may involve different mechanisms. Thus, the metabolism of the 3,500-mol wt fraction is dependent upon glomerular filtration, while the uptake of the 9,000-mol wt material can proceed in its absence, as long as renal tissue remains adequately perfused. This finding suggests that the 9,000-mol wt component may be handled by peritubular uptake.This publication has 28 references indexed in Scilit:
- HETEROGENEITY OF PLASMA GLUCAGON: PATTERNS IN PATIENTS WITH CHRONIC RENAL FAILURE AND DIABETES.Journal of Clinical Endocrinology & Metabolism, 1976
- Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dogMetabolism, 1975
- Evidence for Sequential Metabolic Cleavage of Proglucagon to Glucagon in Glucagon BiosynthesisEndocrinology, 1975
- Cholecystokinin Metabolism in Man and DogsAnnals of Surgery, 1975
- Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogsMetabolism, 1975
- Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.Journal of Clinical Investigation, 1975
- Measurement of Renal Blood Flow in the RatExperimental Biology and Medicine, 1975
- Hyperglucagonemia in Uremia: Reversal by Renal TransplantationAnnals of Internal Medicine, 1975
- Isolation and partial characterization of anglerfish proglucagonBiochemistry, 1975
- Renal handling of low molecular weight proteinsAmerican Journal Of Medicine, 1975